Medicația și hormonii în FIV: ghid complet al protocoalelor de stimulare
Protocoale de stimulare FIV: FSH recombinant, HMG, antagoniști GnRH, agoniști, trigger HCG vs agonist, progesteron suport. Protocol lung, scurt și antagonist.

Întrebări frecvente
Bosch E, Broer S, Griesinger G, Macklon N, Fauser BC ESHRE guideline: ovarian stimulation for IVF/ICSI. Human Reproduction Open, 2020.
DOI: 10.1093/hropen/hoaa009Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews, 2016.
DOI: 10.1002/14651858.CD001750.pub4Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation. Human Reproduction, 2013.
DOI: 10.1093/humrep/det297van der Linden M, Buckingham K, Farquhar C, Kremer JA Luteal phase support for assisted reproduction cycles. Cochrane Database of Systematic Reviews, 2015.
DOI: 10.1002/14651858.CD009154.pub3Sunkara SK, Rittenberg V, Raine-Fenning N, Bhatt S, Zamora J, Coomarasamy A Association between the number of eggs and live birth in IVF treatment: an analysis of 400,135 treatment cycles. Human Reproduction, 2011.
DOI: 10.1093/humrep/der106La Marca A, Sunkara SK Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update, 2014.
DOI: 10.1093/humupd/dmt037Ubaldi FM, Capalbo A, Vaiarelli A, Cimadomo D, Colamaria S, Alviggi C Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population. Human Reproduction, 2016.
DOI: 10.1093/humrep/dew174Tournaye H, Sukhikh GT, Kahler E, Griesinger G A Phase III randomized controlled trial comparing the efficacy, safety, and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human Reproduction, 2017.
DOI: 10.1093/humrep/dex023


